Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

177Lu-labeled low-molecular-weight agents for PSMA-targeted radiopharmaceutical therapy.

Banerjee SR, Kumar V, Lisok A, Chen J, Minn I, Brummet M, Boinapally S, Cole M, Ngen E, Wharram B, Brayton C, Hobbs RF, Pomper MG.

Eur J Nucl Med Mol Imaging. 2019 Aug 10. doi: 10.1007/s00259-019-04434-0. [Epub ahead of print]

PMID:
31399803
2.

Imaging CAR T cell therapy with PSMA-targeted positron emission tomography.

Minn I, Huss DJ, Ahn HH, Chinn TM, Park A, Jones J, Brummet M, Rowe SP, Sysa-Shah P, Du Y, Levitsky HI, Pomper MG.

Sci Adv. 2019 Jul 3;5(7):eaaw5096. doi: 10.1126/sciadv.aaw5096. eCollection 2019 Jul.

3.

Preclinical evaluation of 203/212Pb-labeled low-molecular-weight compounds for targeted radiopharmaceutical therapy of prostate cancer.

Ray Banerjee S, Minn IL, Kumar V, Josefsson A, Lisok A, Brummet M, Chen J, Kiess A, Baidoo K, Brayton C, Mease RC, Brechbiel M, Sgouros G, Hobbs RF, Pomper MG.

J Nucl Med. 2019 Jun 28. pii: jnumed.119.229393. doi: 10.2967/jnumed.119.229393. [Epub ahead of print]

PMID:
31253744
4.

MRI Assessment of Prostate-Specific Membrane Antigen (PSMA) Targeting by a PSMA-Targeted Magnetic Nanoparticle: Potential for Image-Guided Therapy.

Ngen EJ, Benham Azad B, Boinapally S, Lisok A, Brummet M, Jacob D, Pomper MG, Banerjee SR.

Mol Pharm. 2019 May 6;16(5):2060-2068. doi: 10.1021/acs.molpharmaceut.9b00036. Epub 2019 Apr 10.

PMID:
30912947
5.

Evaluation of 111In-DOTA-5D3, a Surrogate SPECT Imaging Agent for Radioimmunotherapy of Prostate-Specific Membrane Antigen.

Banerjee SR, Kumar V, Lisok A, Plyku D, Nováková Z, Brummet M, Wharram B, Barinka C, Hobbs R, Pomper MG.

J Nucl Med. 2019 Mar;60(3):400-406. doi: 10.2967/jnumed.118.214403. Epub 2018 Sep 20.

PMID:
30237212
6.

Brush border enzyme-cleavable linkers: Evaluation for reducing renal uptake of radiolabeled prostate-specific membrane antigen inhibitors.

Vaidyanathan G, Kang CM, McDougald D, Minn I, Brummet M, Pomper MG, Zalutsky MR.

Nucl Med Biol. 2018 Jul - Aug;62-63:18-30. doi: 10.1016/j.nucmedbio.2018.05.002. Epub 2018 May 5.

7.

Airway glycomic and allergic inflammatory consequences resulting from keratan sulfate galactose 6-O-sulfotransferase (CHST1) deficiency.

Kumagai T, Kiwamoto T, Brummet ME, Wu F, Aoki K, Zhu Z, Bochner BS, Tiemeyer M.

Glycobiology. 2018 Jun 1;28(6):406-417. doi: 10.1093/glycob/cwy025.

8.

[64Cu]XYIMSR-06: A dual-motif CAIX ligand for PET imaging of clear cell renal cell carcinoma.

Minn I, Koo SM, Lee HS, Brummet M, Rowe SP, Gorin MA, Sysa-Shah P, Lewis WD, Ahn HH, Wang Y, Banerjee SR, Mease RC, Nimmagadda S, Allaf ME, Pomper MG, Yang X.

Oncotarget. 2016 Aug 30;7(35):56471-56479. doi: 10.18632/oncotarget.10602.

9.

(2S)-2-(3-(1-Carboxy-5-(4-211At-Astatobenzamido)Pentyl)Ureido)-Pentanedioic Acid for PSMA-Targeted α-Particle Radiopharmaceutical Therapy.

Kiess AP, Minn I, Vaidyanathan G, Hobbs RF, Josefsson A, Shen C, Brummet M, Chen Y, Choi J, Koumarianou E, Baidoo K, Brechbiel MW, Mease RC, Sgouros G, Zalutsky MR, Pomper MG.

J Nucl Med. 2016 Oct;57(10):1569-1575. Epub 2016 May 26.

10.

Imaging of carbonic anhydrase IX with an 111In-labeled dual-motif inhibitor.

Yang X, Minn I, Rowe SP, Banerjee SR, Gorin MA, Brummet M, Lee HS, Koo SM, Sysa-Shah P, Mease RC, Nimmagadda S, Allaf ME, Pomper MG.

Oncotarget. 2015 Oct 20;6(32):33733-42. doi: 10.18632/oncotarget.5254.

11.

Endogenous airway mucins carry glycans that bind Siglec-F and induce eosinophil apoptosis.

Kiwamoto T, Katoh T, Evans CM, Janssen WJ, Brummet ME, Hudson SA, Zhu Z, Tiemeyer M, Bochner BS.

J Allergy Clin Immunol. 2015 May;135(5):1329-1340.e9. doi: 10.1016/j.jaci.2014.10.027. Epub 2014 Dec 12.

12.

Mechanisms of Siglec-F-induced eosinophil apoptosis: a role for caspases but not for SHP-1, Src kinases, NADPH oxidase or reactive oxygen.

Mao H, Kano G, Hudson SA, Brummet M, Zimmermann N, Zhu Z, Bochner BS.

PLoS One. 2013 Jun 28;8(6):e68143. doi: 10.1371/journal.pone.0068143. Print 2013.

13.

Mice deficient in the St3gal3 gene product α2,3 sialyltransferase (ST3Gal-III) exhibit enhanced allergic eosinophilic airway inflammation.

Kiwamoto T, Brummet ME, Wu F, Motari MG, Smith DF, Schnaar RL, Zhu Z, Bochner BS.

J Allergy Clin Immunol. 2014 Jan;133(1):240-7.e1-3. doi: 10.1016/j.jaci.2013.05.018. Epub 2013 Jul 2.

14.

Characterization of expression of glycan ligands for Siglec-F in normal mouse lungs.

Guo JP, Brummet ME, Myers AC, Na HJ, Rowland E, Schnaar RL, Zheng T, Zhu Z, Bochner BS.

Am J Respir Cell Mol Biol. 2011 Feb;44(2):238-43. doi: 10.1165/rcmb.2010-0007OC. Epub 2010 Apr 15.

15.

The effect of etanercept on the human cutaneous allergic response.

Conner E, Bochner BS, Brummet M, Beck LA.

J Allergy Clin Immunol. 2008 Jan;121(1):258-60. doi: 10.1016/j.jaci.2007.10.044. No abstract available.

PMID:
18206514
16.

Functional analysis of the chemokine receptor CCR3 on airway epithelial cells.

Beck LA, Tancowny B, Brummet ME, Asaki SY, Curry SL, Penno MB, Foster M, Bahl A, Stellato C.

J Immunol. 2006 Sep 1;177(5):3344-54.

17.

Polymorphisms in the novel gene acyloxyacyl hydroxylase (AOAH) are associated with asthma and associated phenotypes.

Barnes KC, Grant A, Gao P, Baltadjieva D, Berg T, Chi P, Zhang S, Zambelli-Weiner A, Ehrlich E, Zardkoohi O, Brummet ME, Stockton M, Watkins T, Gao L, Gittens M, Wills-Karp M, Cheadle C, Beck LA, Beaty TH, Becker KG, Garcia JG, Mathias RA.

J Allergy Clin Immunol. 2006 Jul;118(1):70-7. Epub 2006 May 30.

PMID:
16815140
18.

Expression of the C-C chemokine receptor CCR3 in human airway epithelial cells.

Stellato C, Brummet ME, Plitt JR, Shahabuddin S, Baroody FM, Liu MC, Ponath PD, Beck LA.

J Immunol. 2001 Feb 1;166(3):1457-61.

19.

Expression and function of P-selectin glycoprotein ligand 1 (CD162) on human basophils.

Taylor ML, Brummet ME, Hudson SA, Miura K, Bochner BS.

J Allergy Clin Immunol. 2000 Nov;106(5):918-24.

PMID:
11080715
20.

Activation of human leukocytes reduces surface P-selectin glycoprotein ligand-1 (PSGL-1, CD162) and adhesion to P-selectin in vitro.

Davenpeck KL, Brummet ME, Hudson SA, Mayer RJ, Bochner BS.

J Immunol. 2000 Sep 1;165(5):2764-72.

21.

Cutaneous injection of human subjects with macrophage inflammatory protein-1 alpha induces significant recruitment of neutrophils and monocytes.

Lee SC, Brummet ME, Shahabuddin S, Woodworth TG, Georas SN, Leiferman KM, Gilman SC, Stellato C, Gladue RP, Schleimer RP, Beck LA.

J Immunol. 2000 Mar 15;164(6):3392-401.

22.

Glucocorticoids inhibit calcium- and calcineurin-dependent activation of the human IL-4 promoter.

Chen R, Burke TF, Cumberland JE, Brummet M, Beck LA, Casolaro V, Georas SN.

J Immunol. 2000 Jan 15;164(2):825-32.

23.

Analysis of the three-dimensional antigenic structure of giant ragweed allergen, Amb t 5.

Rafnar T, Brummet ME, Bassolino-Klimas D, Metzler WJ, Marsh DG.

Mol Immunol. 1998 Jun;35(8):459-67.

PMID:
9798650
24.

Stimulation of the high-affinity IgE receptor results in the tyrosine phosphorylation of a 60 kD protein which is associated with the protein-tyrosine kinase, Csk.

Rafnar T, Peebles RS, Brummet ME, Catipović B, Imani F, MacGlashan DW, Marsh DG.

Mol Immunol. 1998 Mar;35(4):249-57.

PMID:
9736341
25.

Csk is constitutively associated with a 60-kDa tyrosine-phosphorylated protein in human T cells.

Catipović B, Schneck JP, Brummet ME, Marsh DG, Rafnar T.

J Biol Chem. 1996 Apr 19;271(16):9698-703.

26.

Csk associates with the TCR zeta and epsilon chains through its SH2 domain.

Rafnar T, Schneck JP, Brummet ME, Marsh DG, Catipović B.

Ann N Y Acad Sci. 1995 Sep 7;766:206-8. No abstract available.

PMID:
7486659

Supplemental Content

Loading ...
Support Center